NTRA - Natera plunges on new short call from Hindenburg Research (update)

Update 10:53am: Adds analyst comment, updates shares. Natera Inc. (NASDAQ:NTRA) dropped 30% after Hindenburg Research released a new short report on the prenatal testing company. Hindenburg alleges that Natera's revenue growth has been "fueled by deceptive sales and billing practices." The short report notes the company is still "starkly unprofitable." Natera (NTRA) didn't immediately respond to Seeking Alpha email request for comment. Raymond James analyst Andrew Cooper, who hosted an investor event with the company earlier on Wednesday, said in a note that the company had a "strong denial" of any "improper" relationship with MGML. Natera short interest is 6%. Last month, Natera reported Q4 GAAP EPS of -$1.48 missed by $0.18, revenue of $173M beat by $4.19M. Natera presented earlier at the Raymond James 43rd Annual Institutional Investors Conference.

For further details see:

Natera plunges on new short call from Hindenburg Research (update)